The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Interim decisions in oncology trials.
Bin Yao
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Kathy Zhang
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Yannis Jemiai
No relevant relationships to disclose
David D. Chang
Employment or Leadership Position - Amgen
Stock Ownership - Amgen